Our Services
Medical Information
Helpful Resources
Published on: 12/9/2025
Childhood alopecia areata itself is not linked to a higher cancer risk later in life, as current studies don’t show increased overall malignancy rates. There are several factors to consider—especially any past systemic treatments (steroids, methotrexate/cyclosporine, JAK inhibitors) and your family history and lifestyle—which can affect monitoring and screening; see the details below to understand important nuances and the best next steps to discuss with your doctor.
If you experienced alopecia areata as a child, you may wonder whether that hair-loss condition affects your risk of developing cancer later in life. Here’s a clear, evidence-based look at what we know—grounded in peer-reviewed research—and what you can do next.
Alopecia areata (AA) is an autoimmune condition in which your immune system mistakenly attacks the hair follicles, causing hair loss—often in round patches on the scalp, eyebrows or elsewhere.
Reference: Pratt et al. (2017), “Alopecia areata,” Nat Rev Dis Primers.
Autoimmune diseases can alter cancer risk in various ways:
Unlike systemic autoimmune diseases, alopecia areata primarily targets hair follicles without widespread organ damage or chronic internal inflammation.
Large-scale studies specifically examining cancer rates in people with childhood alopecia areata are limited. However:
In short, having had childhood AA alone is not recognized as a cancer-predisposing condition.
While AA itself isn’t linked to cancer, some treatments used—especially for severe or chronic AA—carry their own risk profiles. If you underwent or are undergoing any of the following, discuss long-term monitoring with your doctor:
Systemic corticosteroids
• High-dose oral steroids can suppress your immune system.
• Prolonged use may slightly increase infection risk; long-term cancer risk is not clearly elevated but should be reviewed with your physician.
Methotrexate or cyclosporine
• Both are immunosuppressants sometimes used for extensive or resistant AA.
• They carry small risks for certain infections and, in rare cases, blood-related cancers.
JAK inhibitors (tofacitinib, ruxolitinib)
• Newer targeted therapies showing promise for AA.
• Early studies suggest safety in the short term; long-term data are still emerging regarding malignancy risk.
If you received any of these treatments as a child, let your current healthcare provider know—especially if you transition care from a pediatrician to an adult specialist.
Your overall cancer risk depends on many factors beyond childhood AA:
Maintaining healthy habits and preventive screenings is key for everyone, regardless of past AA.
Monitor general health
Review past treatments
Stay informed on AA resources
While childhood AA itself doesn’t raise cancer risk, it’s important to talk to a doctor if you experience:
If any symptoms could be life-threatening or serious, seek medical care immediately.
Always remember: this information is educational and not a substitute for professional medical advice. If you have any worries about your past alopecia or your long-term health, speak to a doctor who can evaluate your individual situation and guide appropriate follow-up.
(References)
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.